Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Clinical Laserthermia Systems AB    CLSRB   SE0002756130

CLINICAL LASERTHERMIA SYSTEMS AB

(CLSRB)
My previous session
Most popular
  Report  
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector news
The feature you requested does not exist. However, we suggest the following feature:

Clinical Laserthermia : CLS participates with hands-on workshop and symposium at the "European Conference on Interventional Oncology", April 8-11, in Amsterdam

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/21/2019 | 03:33am EST

Clinical Laserthermia Systems (CLS) (publ), participates at the European Conference on Interventional Oncology ECIO in Amsterdam, the Netherlands, April 8-11. CLS is Gold Sponsor this year, which means increasing our visibility during the event, among other things by organizing one hour's symposium focusing on imILT®, the method in an immunological context and presenting the studies we carry out on pancreatic cancer indication. The symposium is held in collaboration with Dr Belarmino Gonçalves, Professor Olivier Turrini, Professor Gunnar Hedlund and, the co-founder, Professor Karl-Göran Tranberg, who will all talk about different aspects of imILT. The symposium will take place on Tuesday April 9thand is chaired by Professor Andreas Mahnken.

On Wednesday, April 10th, CLS will participate in a hands-on workshop for "Tumor ablation". The purpose of ECIO's hands-on workshops is that different industrial players, in an educational format, get the opportunity to show their technology and share knowledge and experience in various medical indications.

At ECIO, CLS also, in addition to the symposium and workshop, has a booth where we demonstrate the TRANBERG® | Thermal Therapy System, including our non-cooled fiber and instruments. We also show the concept of the navigation platform for MR temperature monitoring, that we are currently developing within the framework of our partnerships with Image Guided Therapy SA (IGT) and Siemens Healthineers.

ECIO was held for the first time in 2008 and since 2012 it is an annual conference, aimed for experts in interventional oncology, i.e. interventional radiology focusing on future for cancer treatment. These treatments are typically less invasive than traditional surgery and are performed by image guidance such as computer tomography (CT) or magnetic resonance imaging (MRI) or ultrasound (US). CLS is a member of the CIRSE (Cardiovascular and Interventional Radiological Society of Europe) organization behind the conference. Last year's ECIO in Vienna had more than 1,400 participants, which is a record for the event.

More information is available on ECIO at www.ecio.org 

                               

This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. 

Lars-Erik Eriksson, CEO, Clinical Laserthermia Systems AB (publ)
Tel: +46 - (0)702 - 90 33 00   E-mail: lee@clinicallaser.se

Clinical Laserthermia Systems AB (publ),develops and sells the TRANBERG®|Thermal Therapy System and specially designed sterile disposable products for safe, gentle and effective treatment of cancerous tumors. The products are marketed for image-guided laser ablation and for treatment with immuno-stimulating interstitial laser thermotherapy, imILT®. The company, which is headquartered in Lund Sweden and has a subsidiary in Berlin, Germany and Boston, MA, USA, is listed Nasdaq First North under the ticker CLS B. Certified Adviser:Västra Hamnen Corporate Finance AB, Tel: +46 40 200 250, E-mail: ca@vhcorp.se. Further information is available on www.clinicallaser.se

http://news.cision.com/cls/r/cls-participates-with-hands-on-workshop-and-symposium-at-the--european-conference-on-interventional-,c2746020

https://mb.cision.com/Main/11591/2746020/995056.pdf

(c) 2019 Cision. All rights reserved., source Press Releases - English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLINICAL LASERTHERMIA SYST
02/21CLINICAL LASERTHERMIA : CLS participates with hands-on workshop and symposium at..
AQ
01/08CLS signs agreement with Siemens Healthineers to secure optimal interfacing t..
AQ
2018CLINICAL LASERTHERMIA : CLS report to EU Horizon2020 shows continued promising s..
AQ
2018CLINICAL LASERTHERMIA : MRI Interventions and Clinical Laserthermia Systems (CLS..
AQ
2018CLINICAL LASERTHERMIA : MRI Interventions and Clinical Laserthermia Systems (CLS..
AQ
2018CLINICAL LASERTHERMIA : CLS Signs Exclusive Distribution Agreement with MRI Inte..
AQ
2018CLINICAL LASERTHERMIA : CLS) and MRI Interventions Announce Collaboration to Dev..
AQ
2018CLINICAL LASERTHERMIA : CLS and MRI Interventions Announce Collaboration to Deve..
AQ
2018CLINICAL LASERTHERMIA : CLS signs agreement with IGT for development and commerc..
AQ
2018CLINICAL LASERTHERMIA : to Exhibit at DMIs Prostate MRI and MR-Guided Interventi..
AQ
More news
Financials (SEK)
Sales 2019 16,9 M
EBIT 2019 -32,0 M
Net income 2019 -32,0 M
Debt 2019 9,00 M
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020
EV / Sales 2019 17,2x
EV / Sales 2020 3,55x
Capitalization 281 M
Chart CLINICAL LASERTHERMIA SYSTEMS AB
Duration : Period :
Clinical Laserthermia Systems AB Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Lars-Erik Thomas Eriksson Chief Executive Officer & Director
Hans von Celsing Executive Chairman
Stephan Carl-Otto Dymling Chief Technical Officer
Mats Ekelund Chief Medical Officer
Karl-Göran Tranberg Director & Senior Medical Advisor
Sector and Competitors
1st jan.Capitalization (M$)
CLINICAL LASERTHERMIA SYSTEMS AB30
THERMO FISHER SCIENTIFIC12.70%101 228
DANAHER CORPORATION9.03%78 802
INTUITIVE SURGICAL14.81%62 954
BOSTON SCIENTIFIC CORPORATION13.50%55 605
ILLUMINA0.77%43 641